Correction to: Concurrent management of multiple sclerosis and natalizumab‑induced hepatitis with ofatumumab: a case report
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Correction to: Concurrent management of multiple sclerosis and natalizumab‑induced hepatitis with ofatumumab: a case report ; volume:45 ; number:10 ; day:17 ; month:7 ; year:2024 ; pages:5115 ; date:10.2024
Neurological sciences ; 45, Heft 10 (17.7.2024), 5115, 10.2024
- Urheber
-
Haggiag, Shalom
Giannelli, Valerio
Prosperini, Luca
Cruciani, Alessandro
Baiocchini, Andrea
Ruggieri, Serena
Pellicelli, Adriano
Gasperini, Claudio
Tortorella, Carla
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10072-024-07694-3
- URN
-
urn:nbn:de:101:1-2412102124573.145960218211
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Haggiag, Shalom
- Giannelli, Valerio
- Prosperini, Luca
- Cruciani, Alessandro
- Baiocchini, Andrea
- Ruggieri, Serena
- Pellicelli, Adriano
- Gasperini, Claudio
- Tortorella, Carla
- SpringerLink (Online service)
Ähnliche Objekte (12)
Concurrent management of multiple sclerosis and natalizumab-induced hepatitis with ofatumumab: a case report
Natalizumab May Improve Cognition and Mood in Multiple Sclerosis
Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists
Concurrent gliomas in patients with multiple sclerosis
Bruising following natalizumab infusion for relapsing-remitting multiple sclerosis: a case report
Bilateral acute retinal necrosis in a patient with multiple sclerosis on natalizumab
Multiple sclerosis disease activity and disability following discontinuation of natalizumab for pregnancy
Extended interval dosing strategies in multiple sclerosis: insights from natalizumab and ocrelizumab trials
GP6 rs2304166 polymorphism is associated with response to natalizumab in multiple sclerosis patients
Pediatric-onset Multiple Sclerosis treatment: a multicentre observational study comparing natalizumab with fingolimod
Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study
FCGR2A rs1801274 polymorphism is associated with response to natalizumab in multiple sclerosis patients
Concurrent management of multiple sclerosis and natalizumab-induced hepatitis with ofatumumab: a case report
Natalizumab May Improve Cognition and Mood in Multiple Sclerosis
Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists
Concurrent gliomas in patients with multiple sclerosis
Bruising following natalizumab infusion for relapsing-remitting multiple sclerosis: a case report
Bilateral acute retinal necrosis in a patient with multiple sclerosis on natalizumab
Multiple sclerosis disease activity and disability following discontinuation of natalizumab for pregnancy
Extended interval dosing strategies in multiple sclerosis: insights from natalizumab and ocrelizumab trials
GP6 rs2304166 polymorphism is associated with response to natalizumab in multiple sclerosis patients
Pediatric-onset Multiple Sclerosis treatment: a multicentre observational study comparing natalizumab with fingolimod
Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study
FCGR2A rs1801274 polymorphism is associated with response to natalizumab in multiple sclerosis patients
Concurrent management of multiple sclerosis and natalizumab-induced hepatitis with ofatumumab: a case report
Natalizumab May Improve Cognition and Mood in Multiple Sclerosis
Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists
Concurrent gliomas in patients with multiple sclerosis
Bruising following natalizumab infusion for relapsing-remitting multiple sclerosis: a case report
Bilateral acute retinal necrosis in a patient with multiple sclerosis on natalizumab
Multiple sclerosis disease activity and disability following discontinuation of natalizumab for pregnancy
Extended interval dosing strategies in multiple sclerosis: insights from natalizumab and ocrelizumab trials
GP6 rs2304166 polymorphism is associated with response to natalizumab in multiple sclerosis patients
Pediatric-onset Multiple Sclerosis treatment: a multicentre observational study comparing natalizumab with fingolimod
Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study